Do you know why Digital Health and Digital Therapeutics (DTx) is gaining the interest of medical device and pharma companies? DTx is a rapidly emerging field that combines advanced digital technologies with clinical evidence to provide personalized and effective treatments to patients.
In this 30-minute educational session, you’ll learn more about this exciting field.
- Explore the challenges DTx companies face during payer negotiations and how this can impact pricing models due to traditional reimbursement schemes that do not fit into the DTx reimbursement model.
- Analyze and discuss the obstacles that DTx manufacturers face in Europe due to the lack of Europe-wide regulation for these therapies.
- Explore the German procedure that is considered a pioneer in the regulation of DTx and its potential impact on the broader European market.
Presenter:
Alejandra Garitonandia
Industry Principal of Life Sciences at Vistex EMEA